BBI-355 is an oral, potent, and selective small molecule CHK1 inhibitor with an IC50 of 0.3 nM. It exhibits significant antitumor activity, both as a monotherapy and in combination with targeted therapies, across various ecDNA+ oncogene-amplified tumor models.
Molecular Weight:
377.4
CAS Number:
[2871056-82-3]
Formula:
C19H19N7O2
Target:
Chk
T207786
* VAT and and shipping costs not included. Errors and price changes excepted
